You have 9 free searches left this month | for more free features.

vorinostat

Showing 26 - 50 of 154

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, Solid Tumor Trial in Rockledge (drug, procedure, other)

Completed
  • Lymphoma
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Rockledge, Pennsylvania
    Fox Chase Cancer Center
Feb 2, 2021

Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell

Completed
  • Acute Lymphoblastic Leukemia in Remission
  • +6 more
  • Allogeneic Bone Marrow Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 15, 2021

Relapsed or Refractory Multiple Myeloma Trial (Vorinostat, Lenalidomide, Dexamethasone)

Completed
  • Relapsed or Refractory Multiple Myeloma
  • Vorinostat
  • +2 more
  • (no location specified)
Oct 27, 2020

Hodgkin's Disease, Non-Hodgkin's Lymphoma Trial in New York (Vorinostat, Niacinamide, Etoposide)

Completed
  • Hodgkin's Disease
  • Non-Hodgkin's Lymphoma
  • Vorinostat
  • +2 more
  • New York, New York
    Center for Lymphoid Malignancies at CUMC
Nov 5, 2020

Acute Myelogenous Leukemia Trial in Australia, Canada, United States (Decitabine, Vorinostat, Filgrastim (G-CSF))

Completed
  • Acute Myelogenous Leukemia
  • Los Angeles, California
  • +32 more
Jun 22, 2022

Glioblastoma Multiforme, Anaplastic Glioma Trial in Houston (Vorinostat, Isotretinoin, Surgical Resection)

Active, not recruiting
  • Glioblastoma Multiforme
  • Anaplastic Glioma
  • Vorinostat
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 29, 2020

Multiple Myeloma Trial (Vorinostat, Bortezomib)

Completed
  • Multiple Myeloma
  • (no location specified)
Apr 7, 2021

HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)

Active, not recruiting
  • HIV Infections
  • Birmingham, Alabama
  • +13 more
Jan 13, 2022

Cutaneous T-Cell Lymphoma Trial in Worldwide (KW-0761, Vorinostat)

Completed
  • Cutaneous T-Cell Lymphoma
  • KW-0761
  • Vorinostat
  • Birmingham, Alabama
  • +72 more
Jul 22, 2022

Medulloblastoma, Pineoblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified Trial in United States (radiation, drug,

Completed
  • Medulloblastoma
  • +2 more
  • 3-Dimensional Conformal Radiation Therapy
  • +10 more
  • Los Angeles, California
  • +14 more
Jan 12, 2022

Multiple Myeloma, Plasma Cell Tumor Trial in Columbus (lenalidomide, vorinostat)

Completed
  • Multiple Myeloma
  • Plasma Cell Neoplasm
  • Columbus, Ohio
    Ohio State University
May 14, 2020

AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma, Ann Arbor Stage I DLBCL Trial in United States

Completed
  • AIDS-Related Plasmablastic Lymphoma
  • +15 more
  • Montgomery, Alabama
  • +34 more
Feb 23, 2022

Acute Lymphoblastic Leukemia Trial in Canada, United States (ITMHA, Dexamethasone, Mitoxantrone)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Los Angeles, California
  • +17 more
Jun 6, 2022

Breast Tumors Trial in San Francisco (Tamoxifen, Vorinostat, Pembrolizumab)

Terminated
  • Breast Neoplasms
  • San Francisco, California
    University of California, San Francisco Medical Center
Jun 22, 2020

HIV Trial in Brighton, London (Combination Antiretroviral Therapy (cART), Raltegravir, Vorinostat)

Active, not recruiting
  • HIV
  • Combination Antiretroviral Therapy (cART)
  • +4 more
  • Brighton, United Kingdom
  • +5 more
Aug 24, 2021

Recurrent DLBCL, Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory DLBCL Trial in Houston (drug, procedure, other, biological)

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Colorectal Cancer Trial in San Antonio (Vorinostat, Hydroxychloroquine, Regorafenib)

Completed
  • Colorectal Cancer
  • Vorinostat
  • +2 more
  • San Antonio, Texas
    Cancer Therapy and Research Center University of Texas Health Sc
Apr 8, 2020

Advanced Cancer Trial in Houston (Sirolimus, Vorinostat, Everolimus)

Unknown status
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 10, 2020

Uveal Melanoma Trial (Vorinostat)

Withdrawn
  • Uveal Melanoma
  • Vorinostat
  • (no location specified)
Feb 4, 2020

Acute Lymphoblastic Leukemia, Precursor B-Cell Lymphoblastic Leukemia, Precursor T-Cell Lymphoblastic Leukemia Trial in

Terminated
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Los Angeles, California
  • +27 more
Oct 5, 2020

Ann Arbor Stage II Non-Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial

Active, not recruiting
  • Ann Arbor Stage II Non-Hodgkin Lymphoma
  • +2 more
  • Mobile, Alabama
  • +189 more
Jan 28, 2023

Neuroblastoma Trial in United States (Ceritinib, dasatinib, sorafenib)

Recruiting
  • Neuroblastoma
  • Birmingham, Alabama
  • +23 more
Sep 26, 2022

Brain Stem Glioma, Cerebral Astrocytoma, Childhood Cerebellar Anaplastic Astrocytoma Trial in Canada, United States

Active, not recruiting
  • Brain Stem Glioma
  • +4 more
  • Bevacizumab
  • +2 more
  • Birmingham, Alabama
  • +136 more
Oct 15, 2022

Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage I Small Lymphocytic Lymphoma Trial in Seattle

Completed
  • Chronic Lymphocytic Leukemia
  • +8 more
  • Fludarabine Phosphate
  • +3 more
  • Seattle, Washington
  • +1 more
Feb 14, 2020